Volume 1 - Supplement Issue 1: Abstracts of International Tehran Breast Cancer Congress                   Multidiscip Cancer Investig 2017, 1 - Supplement Issue 1: Abstracts of International Tehran Breast Cancer Congress: 0-0 | Back to browse issues page

XML Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Akbariqomi M, Heidari R, Kooshki H, Akbari Nakhjavani S, Sadat Lavasani P, Absalan M, et al . Clinical Application of Circulating Tumor DNA in Diagnosis of Breast Cancer. Multidiscip Cancer Investig. 2017; 1
URL: http://mcijournal.com/article-1-94-en.html
Abstract:   (2708 Views)
Introduction: Breast cancer is the leading cause of death in women over the age of 25 worldwide. In spite of the advancements in diagnostic methods, Surgery and invasive sampling of breast tissue are the only definitive diagnostic processes among breast cancer patients. During tumor development, Tumor cells which undergo necrosis or apoptosis release circulation tumor DNA (ctDNA) into the blood. ctDNA molecules are short fragments with 130-200 base pair (bp) carrying the features of genetic and epigenetic tumor tissues. ctDNA is a potential biomarker for detection, accurately monitoring tumor and treatment response. This review was conducted in English, using search engines Pubmed, Medline/Ovid, Scopus, Science Direct, ProQuest, and Web of Science and search terms including “Diagnosis or detection of breast cancer”, “circulating cell free DNA” and “circulating tumor DNA”.
Conclusion: In this review, we discussed the biological features and clinical applications of circulating tumor DNA in patients with breast cancer.
Full-Text [PDF 61 kb]   (487 Downloads)    
Type of Study: Review Article | Subject: genetics
Received: 2017/10/25 | Accepted: 2017/10/25 | ePublished: 2017/10/25

Add your comments about this article : Your username or Email:

© 2019 All Rights Reserved | Multidisciplinary Cancer Investigation

Designed & Developed by : Yektaweb